Tag Archives: WHO

The race is on to trace the new COVID-19 variant

By Alistair Smout, Francesco Guarascio and Chen Lin

LONDON/BRUSSELS/SINGAPORE (Reuters) – Governments around the world are urgently scouring databases for recent cases of COVID-19 infections, screening travelers and decoding the viral genomes of the new variant as they try to measure how far it has spread.

The pace of the work highlights the pressure on governments and public health authorities to decide quickly whether they need to take unpopular, economically damaging steps to curb Omicron’s spread.

Data shows it was circulating before it was officially identified in southern Africa last week and it has since been detected in more than a dozen countries. Work to establish if it is more infectious, deadly or evades vaccines will take weeks.

Britain and other major economies banned flights to and from southern Africa just days after the variant was first detected, roiling global financial markets and stirring worries about the economic damage.

The speed of the action is in stark contrast to the emergence of other variants – when the first samples of the Alpha variant were documented in Britain in September 2020, the government spent months gathering data and assessing its potential danger before imposing a nationwide lockdown in December.

It took the World Health Organization (WHO) months to designate it a variant of concern – its highest level.

Soon after detecting its first Omicron case on Friday, Israel announced it would buy 10 million more PCR kits that can detect the variant in an effort to contain its spread. It shut its borders to foreigners from all countries on Saturday.

Scotland and Singapore are scrambling to check tens of thousands of recent positive cases for signs of the variant they may have missed and the United States is enhancing its COVID-19 surveillance to distinguish domestic cases of the Omicron variant from the still-dominant Delta.

The European Union’s health commissioner has urged member states to boost efforts to detect mutations, as some still lag behind almost two years into the pandemic.

The bloc has now confirmed 42 cases in 10 countries.

“Certain Member States lag behind considerably in terms of this crucial dimension,” Stella Kyriakides said in a letter seen by Reuters to health ministers of the 27 EU countries.

“Already faced with a challenging winter due to the high transmissibility of the Delta variant (…) we may now experience further or additional pressures because of the appearance of the Omicron variant,” she wrote.

ALL ABOUT THE S-GENE

Most PCR tests cannot distinguish Omicron from the Delta variant, the dominant and most infectious version of the virus so far.

To distinguish Omicron from Delta, the PCR test must be able to identify a mutation in Omicron known as the S-gene drop-out or S-gene target failure (SGTF).

It is not a fail-safe because the Alpha variant, first identified in Britain, also has that mutation.

Given that Alpha is no longer widely circulating, the presence of the S-gene dropout suggests the sample is positive for Omicron and alerts the lab to send the sample for genome sequencing for confirmation.

If local PCR tests cannot identify this mutation, then randomly selected PCR swab samples must undergo genome sequencing, which can take up to a week.

The WHO has said that widely available tests are able to detect individuals infected with any variant, including Omicron.

However, it has so far only recommended the TaqPath test produced by U.S. firm Thermo Fisher as a proxy.

It’s not clear if countries will buy kits due to the unique characteristic of the test. Singapore is considering buying more, although no decision has yet been made, Kenneth Mak, the health ministry’s director of medical services, told Reuters.

Thermo Fisher has said it is prepared to increase production to meet demand from countries in Africa and elsewhere as they work to track the spread of the new variant.

Within a day of the variant being identified, Israel started checking for the S-Gene in all positive tests taken from travelers arriving at the main Ben Gurion airport, Israel’s head of public health at the Health Ministry, Sharon Alroy-Preis, told Parliament on Sunday.

Now, its labs monitor for that mutation in all tests nationwide and when a positive PCR test indicates SGTF, the sample is taken for further sequencing, the health ministry said.

Most U.S. labs will be using the TaqPath test, Scott Becker, chief executive of the Association of Public Health Laboratories (APHL), a network of state and municipal public health laboratories, told Reuters.

QUIRKS OF THE VARIANT

Out of the 150,000 positive tests going back a month assessed in Belgium, 47 had S-gene drop-out and a high viral load. Only one of them was Omicron, according to Marc Van Rast, one of the virologists who parsed the samples.

The Scottish authorities have gone through swabs back to Nov. 1 to help in discover nine cases of Omicron, all linked to the same event.

They have found that around Nov. 16, S-gene target failure had started appearing in the tests again, a week before South Africa and Botswana identified the new variant. That feature has helped to direct genomic sequencing, as it did when Alpha emerged.

“That is one of the quirks of this particular variant that we can use to our advantage,” Gregor Smith, Scotland’s chief medical officer, said on Monday.

It means the government can start estimating how prevalent the new variant may be, identify people who may need to get tested again and which samples need to be prioritized for further decoding in labs, Smith said.

“It’s the best method that we have to be able to identify cases at this point in time.”

(Reporting by Alistair Smout in London, Francesco Guarascio in Brussels, Chen Lin in Singapore, Julie Steenhuysen in Chicago and Maayan Lubell and Ari Rabinovitch in Jerusalem; Writing by Josephine Mason; Editing by Nick Macfie)

WHO flags Omicron risk, countries tighten curbs, Biden urges vaccination

By Stephanie Nebehay, Alexander Winning and Wendell Roelf

GENEVA/JOHANNESBURG (Reuters) -The World Health Organization (WHO) said on Monday the Omicron coronavirus variant carried a very high risk of infection surges as more countries closed their borders, reviving fears over economic recovery from the two-year pandemic.

Airlines were scrambling to limit the impact of the variant on their networks, while delays in bookings threatened an already fragile recovery for global tourism.

But shares in airlines bounced back with the rest of the market on Monday after a sharp sell-off on Friday as hopes grew that the variant might prove to be milder than initially feared.

The WHO advised its 194 member nations that any surge in infections could have severe consequences, but said no deaths had yet been linked to the new variant.

“Omicron has an unprecedented number of spike mutations, some of which are concerning for their potential impact on the trajectory of the pandemic,” the WHO said.

“The overall global risk related to the new variant of concern Omicron is assessed as very high.”

Further research was needed to understand Omicron’s potential to escape protection against immunity induced by vaccines and previous infections, it said, adding that more data was expected in coming weeks.

U.S. President Joe Biden said the new variant was a cause for concern but not panic and that it would sooner or later arrive in the United States, urging people to get vaccinated. He said it would be weeks before the world knew how effective current vaccines would be against it.

“Obviously, we’re on high alert,” Dr. Anthony Fauci, the top U.S. infectious disease official and Biden’s chief medical adviser, told ABC News. “It’s inevitable that, sooner or later, it’s going to spread widely.”

An infectious disease expert from South Africa, where scientists first identified Omicron, said it was too early to say whether symptoms were more severe than previous variants, but it did appear to be more transmissible.

Professor Salim Abdool Karim also said existing vaccines were probably effective at stopping Omicron from causing severe illness. Scientists have said it could take weeks to understand the severity of Omicron.

South African cases were likely to exceed 10,000 a day this week, rocketing up from barely 300 a day two weeks ago, Karim added.

But South African President Cyril Ramaphosa denounced “unjustified and unscientific” travel bans that damage tourism-reliant economies. His country has said it is being punished for its scientific ability to detect new variants.

After a virtual meeting on Monday, health ministers from the Group of Seven bloc of wealthy nations praised South Africa for its “exemplary work” in detecting the variant and alerting others.

JITTERY MARKETS

Fears the new variant might be resistant to vaccines helped wipe roughly $2 trillion off global stock markets on Friday but markets settled down again on Monday, even after Japan said it would close its borders.

Other countries also imposed travel and other restrictions, worried that Omicron could spread fast even among people with immunity.

Travelers stranded at Johannesburg international airport said they felt helpless as flights from South Africa were cancelled.

“We don’t know what to do, we are just waiting here,” said Ntabiseng Kabeli, a stranded passenger from Lesotho.

Portugal found 13 cases of the variant at a Lisbon football club. Spain, Sweden, Scotland and Austria also reported their first cases.

Japan described its ban on arrivals by foreigners as precautionary.

Health Minister Shigeyuki Goto said tests would determine if a traveler from Namibia was Japan’s first Omicron case.

In Israel, a ban on arrivals by foreigners took effect overnight.

U.N. Secretary-General Antonio Guterres expressed concern that restrictions would leave southern African countries isolated.

“The people of Africa cannot be blamed for the immorally low level of vaccinations available in Africa – and they should not be penalized for identifying and sharing crucial science and health information with the world,” he said.

Guterres has long warned about the dangers of vaccine inequality around the world and that low immunization rates are “a breeding ground for variants.”

More than 261 million people in over 210 countries have been reported to be infected by the coronavirus since the first cases were identified in China in December 2019 and 5,456,515​ have died, according to a Reuters tally.

The new variant was discovered just as many parts of Europe were suffering a fourth wave of coronavirus infections as winter grips the continent in the runup to Christmas, with more people gathering indoors and increasing the risk of infection.

European Central Bank chief Christine Lagarde tried to reassure investors that the euro zone could cope with a resurgence of infections.

“We now know our enemy and what measures to take,” she told Italian broadcaster RAI late on Sunday. “We are all better equipped to respond to a risk of a fifth wave or the Omicron variant.”

(Reporting by Reuters bureaus; Writing by Himani Sarkar, Catherine Evans and Nick Macfie; Editing by Clarence Fernandez and Peter Graff)

World at risk of measles outbreaks as COVID-19 disrupts infant shots, report says

(Reuters) – The risk of measles outbreaks is high after more than 22 million infants missed their first vaccine doses during the COVID-19 pandemic in 2020, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) warned.

Reported measles cases fell by more than 80% last year compared with 2019, but a higher number of children missing their vaccine doses leaves them vulnerable, a joint report by the WHO and the U.S. CDC showed on Wednesday.

About 3 million more children missed the shots in 2020 than the previous year, the largest increase in two decades, threatening global efforts to eventually eradicate the highly infectious viral disease.

“Large numbers of unvaccinated children, outbreaks of measles, and disease detection and diagnostics diverted to support COVID-19 responses are factors that increase the likelihood of measles-related deaths and serious complications in children,” the U.S. CDC’s immunization head, Kevin Cain, said.

Measles is one of the most contagious diseases known, more so than COVID-19, Ebola, tuberculosis or flu. It can be especially dangerous for babies and young children, with pneumonia among the possible complications.

In 2019, reported cases of measles were at their highest in almost a quarter of a century.

The latest report said 24 measles vaccination campaigns originally planned for 2020 in 23 countries were postponed, leaving more than 93 million people at risk.

“It’s critical that countries vaccinate as quickly as possible against COVID-19, but this requires new resources so that it does not come at the cost of essential immunization programs,” said Dr Kate O’Brien, director of the WHO’s department of immunization, vaccines and biologicals.

“Routine immunization must be protected and strengthened; otherwise, we risk trading one deadly disease for another,” she said.

(Reporting by Amna Karimi and Pushkala Aripaka in Bengaluru; Editing by Devika Syamnath)

WHO says it may be ‘last chance’ to find COVID origins

By Stephanie Nebehay and Pushkala Aripaka

GENEVA (Reuters) -The World Health Organization (WHO) said on Wednesday its newly formed advisory group on dangerous pathogens may be “our last chance” to determine the origins of the SARS-CoV-2 virus and called for cooperation from China.

The first human cases of COVID-19 were reported in the central Chinese city of Wuhan in December 2019. China has repeatedly dismissed theories that the virus leaked from one of its laboratories and has said no more visits are needed.

A WHO-led team spent four weeks in and around Wuhan earlier this year with Chinese scientists, and said in a joint report in March that the virus had probably been transmitted from bats to humans through another animal but further research was needed.

WHO director-general Tedros Adhanom Ghebreyesus has said that the investigation was hampered by a dearth of raw data pertaining to the first days of the outbreak’s spread and has called for lab audits.

The WHO on Wednesday named the 26 proposed members of its Scientific Advisory Group on the Origins of Novel Pathogens (SAGO). They include Marion Koopmans, Thea Fischer, Hung Nguyen and Chinese animal health expert Yang Yungui, who took part in the joint investigation in Wuhan.

DOZENS OF STUDIES NEEDED

Maria van Kerkhove, WHO technical lead on COVID-19, voiced hope that there would be further WHO-led international missions to China which would engage the country’s cooperation.

She told a news conference that “more than three dozen recommended studies” still needed to be carried out to determine how the virus crossed from the animal species to humans.

Reported Chinese tests for antibodies present in Wuhan residents in 2019 will be “absolutely critical” to understanding the virus’s origins, van Kerkhove said.

Mike Ryan, WHO’s top emergency expert, said the new panel may be the last chance to establish the origin of SARS-CoV-2, “a virus that has stopped our whole world”.

The WHO was seeking to “take a step back, create an environment where we can again look at the scientific issues,” he said.

Chen Xu, China’s ambassador to the UN in Geneva, told a separate news conference the conclusions of the joint study were “quite clear,” adding that as international teams had been sent to China twice already, “it is time to send teams to other places.”

“I do believe that if we are going to continue with the scientific research I think it should be a joint effort based on science not by the intelligence agencies,” Chen said. “So if we are going to talk about anything, we are doing the whole business with the framework of SAGO”.

(Reporting by Stephanie Nebehay in Geneva and Pushkala Aripaka in Bengaluru; writing by Stephanie Nebehay; Editing by Bernadette Baum)

WHO backs rollout of malaria vaccine for African children

By Maggie Fick and Aaron Ross

NAIROBI (Reuters) -The World Health Organization (WHO) said on Wednesday the only approved vaccine against malaria should be widely given to African children, potentially marking a major advance against a disease that kills hundreds of thousands of people annually.

The WHO recommendation is for RTS,S – or Mosquirix – a vaccine developed by British drugmaker GlaxoSmithKline.

Since 2019, 2.3 million doses of Mosquirix have been administered to infants in Ghana, Kenya and Malawi in a large-scale pilot program coordinated by the WHO. The majority of those whom the disease kills are aged under five.

That program followed a decade of clinical trials in seven African countries.

“This is a vaccine developed in Africa by African scientists and we’re very proud,” said WHO director-general Tedros Adhanom Ghebreyesus.

“Using this vaccine in addition to existing tools to prevent malaria could save tens of thousands of young lives each year,” he added, referring to anti-malaria measures like bed nets and spraying.

Malaria is far more deadly than COVID-19 in Africa. It killed 386,000 Africans in 2019, according to a WHO estimate, compared with 212,000 confirmed deaths from COVID-19 in the past 18 months.

The WHO says 94% of malaria cases and deaths occur in Africa, a continent of 1.3 billion people. The preventable disease is caused by parasites transmitted to people by the bites of infected mosquitoes; symptoms include fever, vomiting and fatigue.

The vaccine’s effectiveness at preventing severe cases of malaria in children is only around 30%, but it is the only approved vaccine. The European Union’s drugs regulator approved it in 2015, saying its benefits outweighed the risks.

“This is how we fight malaria, layering imperfect tools on top of each other,” said Ashley Birkett, who leads global malaria vaccine work at Path, a non-profit global health organization that has funded the development of the vaccine with GSK and the three-country pilot.

Another vaccine against malaria, developed by scientists at Britain’s University of Oxford and called R21/Matrix-M, showed up to 77% efficacy in a year-long study involving 450 children in Burkina Faso, researchers said in April, but it is still in the trial stages.

GSK also welcomed the WHO recommendation.

“This long-awaited landmark decision can reinvigorate the fight against malaria in the region at a time when progress on malaria control has stalled,” Thomas Breuer, Chief Global Health Officer, said in a statement.

GSK shares held steady in New York following the announcement, which came after the close of trading in its London-listed shares.

FUNDING CHALLENGE

The recommendation was jointly announced in Geneva by the WHO’s top advisory bodies for malaria and immunization, the Malaria Policy Advisory Group and the Strategic Advisory Group of Experts on Immunization.

Experts said the challenge now would be mobilizing financing for production and distribution of the vaccine to some of the world’s poorest countries.

GSK has to date committed to produce 15 million doses of Mosquirix annually, in addition to the 10 million doses donated to the WHO pilot programs, up to 2028 at a cost of production plus no more than 5% margin.

A global market study led by the WHO this year projected demand for a malaria vaccine would be 50 to 110 million doses per year by 2030 if it is deployed in areas with moderate to high transmission of the disease.

The GAVI vaccine alliance, a global public-private partnership, will consider in December whether and how to finance the vaccination program.

“As we’ve seen from the COVID vaccine, where there is political will, there is funding available to ensure that vaccines are scaled to the level they are needed,” said Kate O’Brien, Director of WHO’s Department of Immunization, Vaccines and Biologicals.

A source familiar with planning for the vaccine’s development said the price per dose was not yet set, but would be confirmed after GAVI’s funding decision and once there is a clear sense of demand for the vaccine.

The WHO’s decision had personal meaning for Dr. Rose Jalong’o, a vaccinology specialist at the Kenyan health ministry.

“I suffered from malaria as a child and during my internship, and during my clinical years I attended to children in hospital because of severe malaria who needed blood transfusion and unfortunately some of them died.”

“It’s a disease I have grown up with and, seeing all this in my lifetime, it’s an exciting time.”

(Reporting by Maggie Fick in Nairobi and Aaron Ross in Dakar; Editing by Katharine Houreld, Mark Potter and Emelia Sithole-Matarise)

Taliban fire in air to scatter hundreds of protesters in Kabul

(Reuters) – Taliban gunmen fired in the air on Tuesday to scatter protesters in the Afghan capital Kabul, witnesses said, as video showed scores scurrying to escape volleys of gunfire.

Hundreds of men and women shouting slogans such as “Long live the resistance” and “Death to Pakistan” marched in the streets to protest against the Taliban takeover. Neighboring Pakistan has deep ties with the Taliban and has been accused of assisting the Islamist group’s return to power – charges it denies.

“The Islamic government is shooting at our poor people,” one panic-stricken woman on the street says over sounds of gunfire in a video clip shown on Iranian television news. There were no immediate reports of injuries, however.

The Taliban’s rapid advance across Afghanistan as U.S. forces pulled out last month triggered a scramble to leave by people fearing reprisals.

U.S.-led foreign forces evacuated about 124,000 foreigners and at-risk Afghans, but tens of thousands were left behind.

Secretary of State Antony Blinken said the United States was in contact with about 100 Americans who were still in Afghanistan.

About 1,000 people, including Americans, have been stuck in the northern city of Mazar-i-Sharif for days awaiting clearance for charter flights to leave, an organizer told Reuters, blaming the delay on the U.S. State Department.

Blinken, holding talks in Qatar, a key interlocutor with the Taliban, said the problem was one of documents.

“My understanding is that the Taliban have not denied exit to anyone holding a valid document, but they have said those without valid documents, at this point, can’t leave,” he told reporters.

“Because all of these people are grouped together, that’s meant that flights have not been allowed to go … We are not aware of anyone being held on an aircraft, or any hostage-like situation.”

AIRPORT RESTART

At the same news conference, Qatari Foreign Minister Sheikh Mohammed bin Abdulrahman Al Thani said no deal had yet been reached with the Taliban on how Qatar and its partner Turkey could get Kabul airport running again.

“We hope in the next few days we can get to a level where the airport is up and running for passengers and for humanitarian aid as well,” he said.

Turkey says it wants to provide security inside the airport to protect any Turkish staff and safeguard operations, but that the Taliban have insisted no foreign forces can be present.

On Monday, the Islamist militants claimed victory in the Panjshir valley, the last province holding out against it, and promised to name a government soon.

Pictures on social media showed Taliban members standing in front of the Panjshir governor’s compound after days of fighting with the National Resistance Front of Afghanistan (NRFA), commanded by Panjshiri leader Ahmad Massoud.

Massoud denied that his force, consisting of remnants of the Afghan army as well as local militia fighters, was beaten.

“We are in Panjshir and our resistance will continue,” he tweeted. He said he was safe but did not say where.

The Taliban have repeatedly sought to reassure Afghans and foreign countries that they will not return to the brutality of their last reign two decades ago, marked by violent public punishments and the barring of women and girls from public life.

But more than three weeks after seizing Kabul, they have yet to set out their plans.

Asked whether Washington would recognize the Taliban, U.S. President Joe Biden told reporters at the White House on Monday: “That’s a long way off.”

STUDENTS SEGREGATED

Teachers and students at universities in Afghanistan’s largest cities – Kabul, Kandahar and Herat – told Reuters that female students were being segregated in class with curtains, taught separately or limited to some campus areas.

“Putting up curtains is not acceptable,” Anjila, a 21-year-old female student at Kabul University, said by telephone, adding that women had sat apart from males in classrooms before the Taliban took over, but without barriers.

“I really felt terrible when I entered the class … We are gradually going back to 20 years ago.”

The conflict in Afghanistan, coupled with drought and coronavirus, has left 18 million people – almost half the population – in need of humanitarian aid, the International Federation of Red Cross and Red Crescent Societies (IFRC) said.

It said tens of thousands of families had headed for relief camps in urban areas, but found they had neither food nor income.

“Basic services in Afghanistan are collapsing and food and other lifesaving aid is about to run out,” Jens Laerke, spokesperson for the U.N. Office for the Coordination of Humanitarian Affairs (OCHA), told a news conference in Geneva, urging more aid ahead of an international donor conference on Sept. 13.

The World Health Organization is liaising with Qatar on deliveries of urgently needed medical supplies, WHO regional emergency director Rick Brennan said.

Drought and war have forced about 5.5 million Afghans to flee their homes, including more than 550,000 newly displaced in 2021, the International Organization for Migration says.

Western powers say they are prepared to send humanitarian aid, but that broader economic engagement depends on the shape and actions of the Taliban government.

(Reporting by Reuters bureaus; Writing by Clarence Fernandez, Raju Gopalakrishnan and Kevin Liffey; Editing by Alex Richardson)

No evidence that Ivory Coast patient had Ebola, says WHO

(Reuters) -New testing has found no evidence that the woman in Ivory Coast who tested positive earlier this month for Ebola actually had the virus, the World Health Organization (WHO) said on Tuesday.

“WHO considers that the patient did not have Ebola virus disease and further analysis on the cause of her illness is ongoing,” it said in a statement.

The positive result was found by a lab in Ivory Coast but subsequent testing in France came back negative, WHO said.

The initial test led Ivory Coast on Aug. 14 to declare its first Ebola outbreak in over 25 years. The woman had travelled to Ivory Coast’s commercial capital Abidjan from northern Guinea, hundreds of kilometers (miles) away.

More than 140 of the woman’s contact were listed in Guinea and Ivory Coast but none of them developed symptoms or tested positive, WHO said.

Ebola typically kills about half of those it infects, although vaccines and new treatments have proven highly effective in reducing fatality rates.

(Reporting by Aaron Ross; Editing by Leslie Adler and Sandra Maler)

Ivory Coast begins Ebola vaccinations after case confirmed in Abidjan

FILE PHOTO: A health worker fills a syringe with Ebola vaccine before injecting it to a patient, in Goma, Democratic Republic of Congo, August 5, 2019. REUTERS/Baz Ratner/File Photo

By Loucoumane Coulibaly

ABIDJAN (Reuters) -Ivory Coast begin vaccinating health workers in the commercial capital Abidjan against Ebola on Monday after a case of the deadly virus was confirmed over the weekend.

An 18-year-old woman tested positive on Saturday after travelling by bus to Abidjan from neighboring Guinea. It is Ivory Coast’s first confirmed case of Ebola in 25 years.

Workers at the hospital in Abidjan where the woman was admitted were the first to receive vaccinations as the health ministry officially launched its vaccination campaign. The country has 5,000 doses available, the ministry said.

In total, health authorities have identified nine people the woman came into contact with, including three family members and six hospital staffers, the World Health Organization (WHO) told partners in a report. The woman and one suspected Ebola case are in hospital, it said.

The WHO has said it is deeply concerned about the virus’ presence in Abidjan, a densely-populated city of more than 4 million people.

Ebola spreads through contact with body fluids and typically kills about half of those it infects, although vaccines and new treatments have proved highly effective in reducing fatality rates.

In Guinea, the health ministry said on Monday that it would begin vaccinating, although it did not say when. The country was declared free of Ebola on June 19, after a four-month outbreak in the south killed 12 people.

Authorities believe the woman who tested positive travelled from northern Guinea by bus, passing through the Nzerekore region in the southeast, where the last outbreak began.

She then crossed Guinea’s southern border into Ivory Coast and reached Abidjan several hundred kilometers farther south on Aug. 11. She was hospitalized the next day.

WHO said preliminary genetic sequencing showed a close match between her case and the 2014–2016 Ebola outbreak, which killed a record 11,300 people. That epidemic originated in southeastern Guinea before spreading to Liberia and Sierra.

Last week, Guinea confirmed one death from the Marburg virus, West Africa’s first case of the highly infectious hemorrhagic fever which is similar to Ebola.

(Reporting by Loucoumane Coulibaly in Abidjan and Saliou Samb in Conakry; Writing Cooper Inveen; Editing by Aaron Ross, Bernadette Baum and Jonathan Oatis)

WHO seeks to take political heat out of virus origins debate

By Emma Farge

GENEVA (Reuters) – The World Health Organization said on Friday it was setting up a new group to trace the origins of the coronavirus, seeking to end what it called “political point scoring” that had hampered investigations.

The inability of the WHO to say where and how the virus began spreading has fueled tensions among its members, particularly between China, where COVID-19 cases were first identified in Wuhan in late 2019, and the United States.

The WHO called for all governments to cooperate to accelerate studies into the origins of the COVID-19 pandemic and “to depoliticize the situation.”

It specified that a new advisory group called the International Scientific Advisory Group for Origins of Novel Pathogens would support “the rapid undertaking” of further studies.

“We should work all together. You, me, everyone wants to know the origin of worst pandemic in a century,” WHO spokesperson Fadela Chaib said at a U.N. briefing on Friday.

Washington on Friday welcomed the WHO plan, noting the “emphasis on scientific-based studies and data driven efforts to find the origins of this pandemic so that we can better detect, prevent and respond to future disease outbreaks.”

President Joe Biden in late May ordered aides to find answers on COVID-19 origins and report back in 90 days.

In its final report, written jointly with Chinese scientists, a WHO-led team that spent four weeks in and around the city of Wuhan in January and February said that the virus had probably been transmitted from bats to humans through another animal. It said that a leak from a laboratory was “extremely unlikely” as a cause.

However, in a documentary broadcast in his native Denmark on Thursday, the WHO mission leader Peter Ben Embarek said that the lab hypothesis merited further study. Ben Embarek could not be reached by Reuters for further comment on Friday.

A WHO official said that its statement on advancing the virus origins study bore no relation to those remarks, noting that the Ben Embarek interview was filmed months ago.

China said it has never rejected cooperation on tracing COVID-19 origins, state media quoted the country’s vice foreign minister as saying.

(Reporting by Emma Farge, Jacon Gronholt-Pedersen and Gabriel Crossley; Editing by Keith Weir and Jon Boyle)

U.S. Senate passes bill to help Taiwan regain WHO status

WASHINGTON (Reuters) – The U.S. Senate passed a bill late on Thursday calling on the State Department to submit a plan to help Taiwan regain its observer status at the World Health Organization, one of several U.S. bids to boost Taiwan as it faces pressure from Beijing.

Taiwan is excluded from most global organizations such as the WHO, the U.N. health agency, because of the objections of China, which considers the island one of its provinces and not a separate country.

The legislation, passed by unanimous consent, was sponsored by Senators Bob Menendez, the Democratic chairman of the Senate Foreign Relations Committee, and Jim Inhofe, the top Republican on the Senate Armed Services Committee.

The two are also co-chairmen of the Senate Taiwan Caucus.

“The U.S. must continue to stand by Taiwan, and do more to reaffirm our support for our ally’s international engagement,” Menendez said in a statement on Friday.

The measure directs the Secretary of State to establish a strategy for obtaining observer status at the World Health Assembly, the decision-making body of the WHO.

The House of Representatives Foreign Affairs Committee approved a similar bill earlier this year, but there has been no word on when the measure might come up for a vote in the full House.

(Reporting by Patricia Zengerle; Editing by Andrew Heavens)